InvestorsHub Logo

Know-Fear

08/03/22 12:11 PM

#500730 RE: KIPK #500698

Yeah I saw somebody else responding similarly to BSB. I’d remind everyone that Duffy went from NWBO to another monoclonal antibody company Regeneron (Noting their monoclonal COVID-19 treatment is no longer authorized as its not effective on the newer Covid variants). Don’t think chemo is the optimal modality to treat all cancers (especially inside the cranium). But, probably has a place and certainly more closely fits “the one size fits all” business model BP is more comfortable with historically. That stated if the acquisition materializes I would view it as a step towards personalized (autologous) therapies for MRK.